Method for detecting pyrazolopyrimidine benzenesulfonate compound from medicine
时间(min)流动相A(%)流动相B(%)047-5153-492547-5153-492695-1005-03695-1005-036.147-5153-494547-5153-49The invention relates to the technical field of drug analysis, and provides a method for detecting pyrazolopyrimidine benzenesulfonate compounds from drugs, which comprises the following steps: adding a to-be...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | 时间(min)流动相A(%)流动相B(%)047-5153-492547-5153-492695-1005-03695-1005-036.147-5153-494547-5153-49The invention relates to the technical field of drug analysis, and provides a method for detecting pyrazolopyrimidine benzenesulfonate compounds from drugs, which comprises the following steps: adding a to-be-detected drug sample into a mixed solvent of acetonitrile and water, dissolving to obtain a sample solution, detecting by liquid chromatography, and determining the content of the pyrazolopyrimidine benzenesulfonate compounds in the drugs. During the detection of the liquid chromatography, a mobile phase adopts the following gradient elution procedure: time (min), mobile phase A (%) and mobile phase B (%) 047-5153-492547-5153-492695-1005-03695-1005-036.147-5153-494547-5153-49. According to the technical scheme, the problem that an elution system adopted in a detection method in the prior art cannot obtain qualified specificity in the determination of the pyrazolopyrimidine benzenesulfonate impurities is solved; th |
---|